Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●DMFold ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

You can:

Go to the GPCR, ligand, or experimental data tables.
Go to the experimental data table for text mining information in PubMed ID column.
Go to the GPCR page and check other ligands which interact with it.
Go to the ligand page and check other GPCRs which it interacts with.
Go back to previous page.

GPCR

Name	5-hydroxytryptamine receptor 2A
Species	Homo sapiens (Human)
Gene	HTR2A
Synonym	5-HT-2 serotonin receptor 2A serotonin 5HT-2 receptor 5-HT-2A 5-HT2A receptor 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled 5Ht-2 'D' receptor [ Show all ]
Disease	Depression Unspecified Diabetes Erythropoietic porphyria Fibromyalgia Sleep disorders Schizophrenia Psychiatric disorder Pancreatitis Mood disorder Migraine Hemorrhoids Glaucoma Central nervous system disease Cardiovascular disorder Addiction Schizophrenia; Sleep maintenance insomnia Alcohol use disorders Anxiety disorder [ Show all ]
Length	471
Amino acid sequence	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV
UniProt	P28223
Protein Data Bank	6a93, 6a94
GPCR-HGmod model	P28223
3D structure model	This structure is from PDB ID 6a93.
BioLiP	BL0441025,BL0441028, BL0441031, BL0441030,BL0441033, BL0441029,BL0441032, BL0441026, BL0441024,BL0441027
Therapeutic Target Database	T32060
ChEMBL	CHEMBL224
IUPHAR	6
DrugBank	BE0000451

Ligand

Name	Ketanserin
Molecular formula	C22H22FN3O3
IUPAC name	3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-1H-quinazoline-2,4-dione
Molecular weight	395.434
Hydrogen bond acceptor	5
Hydrogen bond donor	1
XlogP	2.6
Synonyms	HMS2094I03 2,4(1H,3H)-Quinazolinedione, 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]- 3-(2-{4-[(4-fluorophenyl)carbonyl]piperidin-1-yl}ethyl)-1,2,3,4-tetrahydroquinazoline-2,4-dione Ketanserina [INN-Spanish] 3-[2-[4-(p-Fluorobenzoyl)piperidino]ethyl]-2,4-(1H,3H)-quinazolinedione LS-140148 NCGC00021146-06 AKOS015895130 NCGC00024865-04 BPBio1_001356 R 41,468 CCG-39512 RL04800 SPECTRUM1505346 FPCCSQOGAWCVBH-UHFFFAOYSA-N Tox21_110865 GS-3601 050K989 I06-0365 3-(2-(4-(4-Fluorobenzoyl)piperidin-1-yl)-ethyl)quinazoline-2,4(1H,3H)-dione Ketanserin tartrate 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)-quinazolinedione Ketanserinum 3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-1,2,3,4-tetrahydroquinazoline-2,4-dione NCGC00021146-01 AB0014126 NCGC00021146-09 API0003079 NSC758959 C-21630 R-41,468 CHEMBL51 SC-17248 DSSTox_GSID_23188 SW196882-3 Vulketan Gel HMS1923O11 KB-67327 3-(2-(4-(p-Fluorobenzoyl)piperidino)ethyl)-2,4-(1H,3H)-quinazolinedione KETANSERIN, Ketanserin tartrate hydrate, KETANSERIN TARTRATE 3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-1H-quinazoline-2,4-dione KS-00000XLH 74050-98-9 NCGC00021146-04 AC1L1GSK NCGC00024865-02 BDBM21395 Perketal CAS-74050-98-9 R41 468 D02363 SMR001550601 EINECS 277-680-2 Taseron [3H]-Ketanserin (+)-3-[2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)-quinazolinedione HMS3655H14 2,4(1H,3H)-Quinazolinedione,3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]- Ketanserin (USAN/INN) 3-(2-{4-[(4-fluorophenyl)carbonyl]piperidin-1-yl}ethyl)quinazoline-2,4(1H,3H)-dione Ketanserine 3-[2-[4-[(4-fluorophenyl)-oxomethyl]-1-piperidinyl]ethyl]-1H-quinazoline-2,4-dione MLS006010073 97F9DE4CT4 NCGC00021146-07 AN-5822 NCGC00024865-05 BRD-K49671696-001-02-1 R 41468 CHEBI:6123 s2232 DB12465 Spectrum2_001713 FT-0630827 Tox21_110865_1 GTPL197 191037-EP2275420A1 K0051 3-(2-(4-(4-Fluorobenzoyl)piperidin-1-yl)ethyl)quinazoline-2,4(1H,3H)-dione Ketanserin [USAN:BAN:INN] 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,4-(1H,3H)-quinazolinedione Ketanserinum [INN-Latin] 3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-1H-quinazoline-2,4-dione NCGC00021146-02 AB2000544 NCGC00021146-12 AX8034794 PDSP1_000639 C07464 R-41-468 CS-6055 SCHEMBL34294 DSSTox_RID_76913 W-104435 HMS2090H18 2,4(1H,3H)-Quinazolinedione, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)- Kentanserin 3-(2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl)-2,4(1H,3H)-quinazolinedione # Ketanserina 3-[2-[4-(4-fluorophenyl)carbonylpiperidin-1-yl]ethyl]-1H-quinazoline-2,4-dione L000764 83846-83-7 NCGC00021146-05 AJ-23373 NCGC00024865-03 Biomol-NT_000096 Pharmakon1600-01505346 CC-29757 R41,468 D08VRO SPBio_001726 F2173-1039 Tocris-0908 [3H]ketanserin FT-0653664 HY-10562 Ketanserin (Vulketan Gel) 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]-ethyl]-2,4-[1H, 3H]-quinazolinedione Ketanserine [INN-French] 3-{2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl}-2,4(1H,3H)-quinazolinedione MolPort-003-666-642 A838000 NCGC00021146-08 AOB5639 NSC-758959 BRD-K49671696-347-02-8 R 41468;Vulketan Gel SBI-0051158.P003 DSSTox_CID_3188 Sufrexal UNII-97F9DE4CT4 GTPL88 191037-EP2280008A2 K261 3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione Ketanserin [USAN:INN:BAN] 3-[2-[4-(4-fluorobenzoyl)-1-piperidyl]ethyl]-1H-quinazoline-2,4-dione Ketaserin 3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}quinazoline-2,4(1H,3H)-dione NCGC00021146-03 AC-2024 NCGC00024865-01 BC202701 PDSP2_000634 C22H22FN3O3 R-41468 CTK8G0431 Serefrex DTXSID3023188 ZINC537877 [ Show all ]
Inchi Key	FPCCSQOGAWCVBH-UHFFFAOYSA-N
Inchi ID	InChI=1S/C22H22FN3O3/c23-17-7-5-15(6-8-17)20(27)16-9-11-25(12-10-16)13-14-26-21(28)18-3-1-2-4-19(18)24-22(26)29/h1-8,16H,9-14H2,(H,24,29)
PubChem CID	3822
ChEMBL	CHEMBL51
IUPHAR	88, 197
BindingDB	21395
DrugBank	DB12465
Structure SDF download
Lipinski's druglikeness	This ligand satisfies Lipinski's rule of five.

Experimental Data

Parameter	Value	Reference	Database source
	N/A	N/A	DrugBank
EC50	1.04 nM	PMID23537943	ChEMBL
IC50	0.35 nM	PMID26988801, PMID27876250	ChEMBL
IC50	0.77 nM	PMID23582449	ChEMBL
IC50	0.9 nM	PMID23466604	ChEMBL
IC50	2.5 nM	PMID18983139	ChEMBL
IC50	2.6 nM	PMID20875743	BindingDB,ChEMBL
IC50	3.5 nM	PMID26988801, PMID27876250	BindingDB
IC50	11.0 nM	PMID25557493	BindingDB,ChEMBL
IC50	13.0 nM	PMID18588282	ChEMBL
IC50	14.0 nM	PMID24805037	BindingDB,ChEMBL
IC50	32.0 nM	PMID19328689, PMID26475518	BindingDB,ChEMBL
IC50	80.0 nM	PMID23675993	ChEMBL
Inhibition	99.6 %	MedChemComm, (2015) 6:5:831	ChEMBL
Inhibition	99.9 %	PMID23675993	ChEMBL
Kb	2.9 nM	PMID24805037	ChEMBL
Kd	0.2 - 2.9 nM	PMID15322733, PMID12738034	IUPHAR
Kd	2.2 nM	PMID18468904	BindingDB
Kd	2.7 nM	PMID18468904	BindingDB
Ke	32.0 nM	PMID20621490	ChEMBL
Ki	0.199 - 7.94 nM	PMID15322733, PMID8845011, PMID12738034	IUPHAR
Ki	0.28 nM	PMID21726069	BindingDB,ChEMBL
Ki	0.3 nM	PMID25557493, PMID24805037	ChEMBL
Ki	0.3 nM	PMID25557493, PMID24805037	BindingDB
Ki	0.39 nM	PMID7582481	PDSP,BindingDB
Ki	0.4 nM	PMID18847250	BindingDB,ChEMBL
Ki	0.49 nM	PMID23466604	ChEMBL
Ki	0.56 nM	Wander et al., PMID1987	PDSP
Ki	1.3 nM	PMID18983139	ChEMBL
Ki	1.34 nM	PMID9225287	PDSP,BindingDB
Ki	2.0 nM	PMID22694093, PMID8845011, PMID16051647	PDSP,BindingDB,ChEMBL
Ki	2.01 nM	PMID8632342	PDSP,BindingDB
Ki	2.03 nM	Andorn et al., PMID1984	PDSP
Ki	2.45 nM	Hoyer et al., PMID1987	PDSP
Ki	2.6 nM	PMID11132243	PDSP,BindingDB
Ki	3.16 nM	PMID7582481	PDSP,BindingDB
Ki	8.12831 nM	PMID15322733	PDSP
Ki	8.13 nM	PMID15322733	BindingDB
Ki	9.8 nM	Elliot & Kent, PMID1989	PDSP
p[A50]	9.1 -	PMID7658443	ChEMBL